WEBINAR - INH & Rifapentine Treatment for LTBI: Expert Opinions About 3HP Utilization

This training is approved for up to 1.5 Category 1 ACCME continuing education hours/nursing education hours & is intended for physicians, nurses, and other health professionals who diagnose and treat patients with latent TB infection (LTBI).  This training opportunity is available to a national audience.  This 90-minute webinar will include a panel of experts discussing the questions healthcare providers have about using 3 months of isoniazid and rifapentine once weekly (3HP) to treat LTBI.  This is part of Curry's On-Demand Webinar series.  For more information about this event, and to register please click here.